Evidence map›Paper›PMID 33847406›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2021

High-Frequency Oscillations in the Pallidum: A Pathophysiological Biomarker in Parkinson's Disease?

Luke A Johnson, Joshua E Aman, Ying Yu, David Escobar Sanabria, Jing Wang, Meghan Hill, Rajiv Dharnipragada, Remi Patriat, Mark Fiecas, Laura Li and 6 more

Open access · greenAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. A next generation neural mass model with neuromodulation.Journal of computational neuroscience · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Paradoxical Modulation of STN β-Band Activity with Medication Compared to Deep Brain Stimulation.Movement disorders : official journal of the Movement Disorder Society · 2024
    Article
  11. Article
  12. Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease.Neuromodulation : journal of the International Neuromodulation Society · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Luke A JohnsonDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-9069-1436
Joshua E AmanDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Ying YuDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
David Escobar SanabriaDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Jing WangDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Meghan HillDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Rajiv DharnipragadaDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Remi PatriatDepartment of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
Mark FiecasSchool of Public Health Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
Laura LiDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Lauren E SchrockDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Scott E CooperDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Matthew D JohnsonDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.
Michael C ParkDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
Noam HarelDepartment of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
Jerrold L VitekDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
University of Minnesota · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Deep Brain Stimulation in the Parkinsonian MonkeyR01NS037019 · NINDS · UNIVERSITY OF MINNESOTA · PI Jerrold L Vitek · 1999 to 2026
$14.5M
TRD4 - Ultrahigh Field Engineering and SafetyP41EB027061 · NIBIB · UNIVERSITY OF MINNESOTA · PI Gregory John Metzger, KAMIL UGURBIL · 2019 to 2026
$11.7M
Neurophysiological Mechanisms Underlying Parkinsonian Motor SignsR01NS058945 · NINDS · UNIVERSITY OF MINNESOTA · PI LUKE Aaron JOHNSON, Jerrold L Vitek · 2008 to 2026
$9.6M
Pathophysiology-based approaches to deep brain stimulation for Parkinson's diseaseP50NS098573 · NINDS · UNIVERSITY OF MINNESOTA · PI JOHNSON, MATTHEW DOUGLAS · 2016 to 2020
$9.1M
Spatiotemporal Optimization of Deep Brain Stimulation for Parkinson's DiseaseR01NS094206 · NINDS · UNIVERSITY OF MINNESOTA · PI Matthew Douglas Johnson, THEODEN I NETOFF · 2016 to 2026
$5.6M
The Effects of Parkinsonism and Deep Brain Stimulation on Basal Ganglia-Thalamocortical Circuitry During Sleep-Wake BehaviorR01NS110613 · NINDS · UNIVERSITY OF MINNESOTA · PI LUKE Aaron JOHNSON · 2019 to 2026
$4.7M
Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian MonkeyR37NS077657 · NINDS · UNIVERSITY OF MINNESOTA · PI VITEK, JERROLD L · 2018 to 2024
$4.4M
Institutional Center Cores for Advanced NeuroimagingP30NS076408 · NINDS · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2020
$4.2M
Optimizing coordinated reset deep brain stimulation for Parkinson's diseaseR01NS117822 · NINDS · UNIVERSITY OF MINNESOTA · PI WANG, JING · 2020 to 2024
$3.0M
Engdahl Family FoundationMnDRIVE (Minnesota's Discovery, Research and Innovation Economy) Brain Conditions ProgramNCATS NIH HHS UL1 TR002494NCATS NIH HHS UL1TR002494NIBIB NIH HHS P41 EB027061NINDS NIH HHS P30 NS076408NINDS NIH HHS P30-NS076408NINDS NIH HHS P41-EB027061NINDS NIH HHS P50 NS098573NINDS NIH HHS P50-NS098573NINDS NIH HHS R01 NS037019NINDS NIH HHS R01-NS037019NINDS NIH HHS R01 NS058945NINDS NIH HHS R01-NS058945NINDS NIH HHS R01 NS094206NINDS NIH HHS R01-NS094206NINDS NIH HHS R01 NS110613NINDS NIH HHS R01-NS110613NINDS NIH HHS R01 NS117822NINDS NIH HHS R37 NS077657The Kurt B. Seydow Dystonia Foundation
6 · The paper itself

Abstract

backgroundAbnormal oscillatory neural activity in the beta-frequency band (13-35 Hz) is thought to play a role in Parkinson's disease (PD); however, increasing evidence points to alterations in high-frequency ranges (>100 Hz) also having pathophysiological relevance.

objectivesStudies have found that power in subthalamic nucleus (STN) high-frequency oscillations is increased with dopaminergic medication and during voluntary movements, implicating these brain rhythms in normal basal ganglia function. The objective of this study was to investigate whether similar signaling occurs in the internal globus pallidus (GPi), a nucleus increasingly used as a target for deep brain stimulation (DBS) for PD.

methodsSpontaneous and movement-related GPi field potentials were recorded from DBS leads in 5 externalized PD patients on and off dopaminergic medication, as well as from 3 rhesus monkeys before and after the induction of parkinsonism with the neurotoxin 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine.

resultsIn the parkinsonian condition, we identified a prominent oscillatory peak centered at 200-300 Hz that increased during movement. In patients the magnitude of high-frequency oscillation modulation was negatively correlated with bradykinesia. In monkeys, high-frequency oscillations were mostly absent in the naive condition but emerged after the neurotoxin 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine. In patients, spontaneous high-frequency oscillations were significantly attenuated on-medication.

conclusionsOur findings provide evidence in support of the hypothesis that exaggerated, movement-modulated high-frequency oscillations in the GPi are pathophysiological features of PD. These findings suggest that the functional role(s) of high-frequency oscillations may differ between the STN and GPi and motivate additional investigations into their relationship to motor control in normal and diseased states.

Indexed as

Deep Brain StimulationParkinson DiseaseSubthalamic NucleusBiomarkersGlobus PallidusHumansBiomarkersdeep brain stimulationhigh-frequency oscillationsinternal globus palliduslocal field potentialsParkinson's disease

Identifiers

PMID33847406
PMCPMC8422942
OpenAlexW3154448890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.